Please note that eDoc will be permanently shut down in the first quarter of 2021!      Home News About Us Contact Contributors Disclaimer Privacy Policy Help FAQ

Home
Search
Quick Search
Advanced
Fulltext
Browse
Collections
Persons
My eDoc
Session History
Login
Name:
Password:
Documentation
Help
Support Wiki
Direct access to
document ID:


          Institute: MPI für molekulare Genetik     Collection: Ribosome Research Groups     Display Documents



  history
ID: 174940.0, MPI für molekulare Genetik / Ribosome Research Groups
Erythromycin, roxithromycin, and clarithromycin: Use of slow-binding kinetics to compare their in vitro interaction with a bacterial ribosomal complex active in peptide bond formation
Authors:Dinos, George P.; Connell, Sean R.; Nierhaus, Knud H.; Kalpaxis, Dimitrios L.
Language:English
Date of Publication (YYYY-MM-DD):2003-03
Title of Journal:Molecular Pharmacology
Journal Abbrev.:Mol. Pharmacol.
Volume:63
Issue / Number:3
Start Page:617
End Page:623
Copyright:© 2003 by The American Society for Pharmacology and Experimental Therapeutics
Review Status:not specified
Audience:Experts Only
Abstract / Description:In a cell-free system derived from Escherichia coli, it is shown that clarithromycin and roxithromycin, like their parent compound erythromycin, do not inhibit the puromycin reaction (i.e., the peptide bond formation between puromycin and AcPhe-tRNA bound at the P-site of 70S ribosomes programmed with heteropolymeric mRNA). Nevertheless, all three antibiotics compete for binding on the ribosome with tylosin, a 16-membered ring macrolide that behaves as a slow-binding, slowly reversible inhibitor of peptidyltransferase. The mutually exclusive binding of these macrolides to ribosomes is also corroborated by the fact that they protect overlapping sites in domain V of 23S rRNA from chemical modification by dimethyl sulfate. From this competition effect, detailed kinetic analysis revealed that roxithromycin or clarithromycin (A), like erythromycin, reacts rapidly with AcPhe-tRNA·MF-mRNA·70S ribosomal complex (C) to form the encounter complex CA which is then slowly isomerized to a more tight complex, termed C*A. The value of the overall dissociation constant, K, encompassing both steps of macrolide interaction with complex C, is 36 nM for erythromycin, 20 nM for roxithromycin, and 8 nM for clarithromycin. Because the off-rate constant of C*A complex does not significantly differ among the three macrolides, the superiority of clarithromycin as an inhibitor of translation in E. coli cells and many Gram-positive bacteria may be correlated with its greater rate of association with ribosomes.
Comment of the Author/Creator:Date: 2003, Mar
External Publication Status:published
Document Type:Article
Communicated by:Ribosome Group
Affiliations:MPI für molekulare Genetik
External Affiliations:Univ Patras, Sch Med, Dept Biochem, Biochem Lab, GR-26500 Patras, Greece.; AG Ribosomen, Max Planck Inst Mol Genet, Berlin, Germany.; Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada
Identifiers:ISI:000181201400019 [ID No:1]
ISSN:0026-895X [ID No:2]
The scope and number of records on eDoc is subject to the collection policies defined by each institute - see "info" button in the collection browse view.